Microfluidic Bone Organoid Chip for 3D Cell Interaction Observation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for studying the ternary regulation theory of angiogenesis, osteoblasts, and osteoclasts are limited by animal models with long experimental cycles and high costs, and traditional two-dimensional cultivation fails to replicate physiological environments, hindering the understanding of bone tissue regulation mechanisms.
Innovation Solution
A microfluidic bone organoid-on-chip is constructed with a visual three-dimensional cell cultivation platform, featuring microfluidic channels for concentration gradient distribution and inclusion of osteoblasts, osteoclasts, and vascular endothelial cells in specific zones to observe interactions and effects of external factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If animal models are used to explore the regulation mechanism of angiogenic-osteogenic coupling, then the physiological environment can be replicated, but the experimental cycle is long and the cost is high
Solution Approach 1:
The patent creates a microfluidic chip that copies the essential features of the bone marrow microenvironment, including three-dimensional spatial arrangement of cells and fluid flow patterns, to replicate physiological conditions without requiring entire animal models. This allows accelerated experimentation while maintaining biological relevance.
Solution Approach 2:
The patent divides the complex animal model system into discrete functional zones within the microfluidic chip, separately cultivating osteoblasts, osteoclasts, and vascular endothelial cells in specific regions while maintaining their interactions. This segmentation enables independent manipulation and observation of each cell type's contribution to the ternary regulation mechanism.
2Ease of manufacture
If traditional two-dimensional cultivation is used, then the experimental setup is simple, but the physiological environment cannot be reproduced well
Solution Approach 1:
The patent transitions from traditional two-dimensional cell cultivation to a three-dimensional microfluidic system that replicates the spatial architecture of bone marrow. The microfluidic channels create a three-dimensional environment where cells are distributed throughout the chip volume, enabling better reproduction of physiological conditions while maintaining experimental accessibility.
Solution Approach 2:
The patent employs microfluidic technology to control fluid flow through the chip, creating controlled micro-environments that replicate the hydraulic conditions of bone marrow. The microfluidic system enables precise control of nutrient delivery, waste removal, and cell-matrix interactions, achieving physiological relevance without excessive complexity.
3Adaptability or versatility
If manual intervention for the ternary regulation mechanism is performed, then the research can be conducted, but the intervention is not controllable and visible
Solution Approach 1:
The patent incorporates real-time monitoring capabilities within the microfluidic chip that allow researchers to observe cell interactions and respond to external factor changes dynamically. The system provides visual feedback on cell behavior, enabling controlled and observable manipulation of the ternary regulation mechanism with precise temporal and spatial resolution.
Solution Approach 2:
The patent creates a dynamic microfluidic system where fluid flow rates, concentrations of external factors, and cell densities can be adjusted in real-time. This dynamic control allows researchers to manipulate the ternary regulation mechanism with precision, observing how changes in one component affect the others while maintaining full controllability and visibility of the experimental process.
Data Source
AI summary
A method for constructing a microfluidic bone organoid-on-chip can continuously observe the impacts of different external factors on a bone tissue structure based on the “ternary regulation theory” of bone angiogenesis-bone resorption-osteogenesis coupling. The method includes: (1) building a visual three-dimensional cell cultivation platform to continuously observe impacts of different external factors on a ternary regulation theory based on angiogenesis of osteoclast precursors, osteoblasts and osteoclasts, such that a user is allowed to directly observe interactions among various kinds of cells; (2) designing microfluidic channels in a chip to allow a reagent involved to present a concentration gradient distribution in the chip; and (3) adding three bioinks including osteoblasts, osteoclasts and vascular endothelial cells respectively, so as to reflect the three cell components individually, in pairs, and as a whole in the chip. An apparatus for constructing a microfluidic bone organoid-on-chip is further provided.